🔎 Trials Near Me

Beranda › Melanoma › Texas › Dallas

Uji klinis Melanoma di Dallas, TX

20 studi untuk Melanoma mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

DESTINY-PANTUMOUR04

Menerima pesertaStudi observasional
  • Research Site, Dallas
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Menerima pesertaFase 3
  • Texas Oncology - Medical City, Dallas
  • Texas Oncology, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Menerima pesertaFase 1/2
  • Baylor, Scott and White Research Institute, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • UT Southwestern Medical Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Menerima pesertaFase 1/2
  • UT Southwestern, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Texas Oncology - Dallas SCRI, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07287917

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Menerima pesertaFase 1/2
  • Texas Oncology, P.A., Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Menerima pesertaFase 1/2
  • Call for Information (Investigational Site 0054), Dallas
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT02332668

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Menerima pesertaStudi observasional
  • University of Texas Southwestern Medical Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06400550

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Mary Crowley Cancer Research, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Menerima pesertaFase 3
  • Texas Retina Associates - Dallas, Dallas
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07015190

A Study of VET3-TGI in Patients With Solid Tumors

Menerima pesertaFase 1
  • Mary Crowley Cancer Research, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Menerima pesertaFase 2/3
  • UT Southwestern Medical Center, Dallas
Semua usia · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Menerima pesertaFase 1/2
  • Research Site, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT06956690

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • NEXT Dallas, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT07317505

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site 120, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Dallas
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Mary Crowley Cancer Research, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Okt 2025 · NCT04370587

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Menerima pesertaFase 1
  • NEXT Oncology, Dallas, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jan 2024 · NCT05746897

Uji klinis Melanoma di kota lain

Studi lain di Dallas

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.